Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 31% ± 10% | |
type I pneumocyte | 3 studies | 24% ± 5% | |
goblet cell | 3 studies | 17% ± 1% |
Insufficient scRNA-seq data for expression of FZD5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 4263.80 | 965 / 966 | 99% | 40.83 | 520 / 527 |
prostate | 100% | 1618.66 | 244 / 245 | 98% | 29.51 | 494 / 502 |
stomach | 100% | 2694.60 | 358 / 359 | 98% | 44.77 | 280 / 286 |
liver | 100% | 3989.89 | 226 / 226 | 97% | 25.77 | 395 / 406 |
pancreas | 100% | 1909.81 | 328 / 328 | 92% | 19.86 | 163 / 178 |
esophagus | 99% | 1289.86 | 1437 / 1445 | 92% | 30.54 | 168 / 183 |
lung | 99% | 2032.43 | 574 / 578 | 91% | 20.18 | 1049 / 1155 |
thymus | 100% | 2452.10 | 652 / 653 | 86% | 14.75 | 522 / 605 |
ovary | 100% | 1163.24 | 180 / 180 | 76% | 15.00 | 328 / 430 |
kidney | 94% | 1047.81 | 84 / 89 | 81% | 15.03 | 734 / 901 |
bladder | 86% | 520.52 | 18 / 21 | 81% | 16.85 | 407 / 504 |
uterus | 88% | 553.93 | 149 / 170 | 61% | 8.35 | 280 / 459 |
adrenal gland | 100% | 1627.09 | 257 / 258 | 49% | 6.17 | 112 / 230 |
breast | 93% | 802.02 | 428 / 459 | 25% | 2.22 | 274 / 1118 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.09 | 1 / 1 |
adipose | 98% | 1045.73 | 1178 / 1204 | 0% | 0 | 0 / 0 |
spleen | 94% | 500.04 | 226 / 241 | 0% | 0 | 0 / 0 |
skin | 49% | 209.38 | 882 / 1809 | 30% | 2.59 | 142 / 472 |
tonsil | 0% | 0 | 0 / 0 | 73% | 9.38 | 33 / 45 |
blood vessel | 71% | 345.26 | 942 / 1335 | 0% | 0 | 0 / 0 |
heart | 64% | 280.89 | 555 / 861 | 0% | 0 | 0 / 0 |
brain | 38% | 173.20 | 999 / 2642 | 25% | 2.26 | 174 / 705 |
muscle | 62% | 265.94 | 501 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 13% | 55.54 | 117 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 10% | 0.97 | 3 / 29 |
eye | 0% | 0 | 0 / 0 | 8% | 0.65 | 6 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002071 | Biological process | glandular epithelial cell maturation |
GO_1901524 | Biological process | regulation of mitophagy |
GO_0001525 | Biological process | angiogenesis |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0002726 | Biological process | positive regulation of T cell cytokine production |
GO_0060718 | Biological process | chorionic trophoblast cell differentiation |
GO_0048596 | Biological process | embryonic camera-type eye morphogenesis |
GO_1901382 | Biological process | regulation of chorionic trophoblast cell proliferation |
GO_0071219 | Biological process | cellular response to molecule of bacterial origin |
GO_0008595 | Biological process | anterior/posterior axis specification, embryo |
GO_0060070 | Biological process | canonical Wnt signaling pathway |
GO_0033077 | Biological process | T cell differentiation in thymus |
GO_0032731 | Biological process | positive regulation of interleukin-1 beta production |
GO_0030182 | Biological process | neuron differentiation |
GO_0060561 | Biological process | apoptotic process involved in morphogenesis |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_2000810 | Biological process | regulation of bicellular tight junction assembly |
GO_0060716 | Biological process | labyrinthine layer blood vessel development |
GO_0060061 | Biological process | Spemann organizer formation |
GO_0060670 | Biological process | branching involved in labyrinthine layer morphogenesis |
GO_0000578 | Biological process | embryonic axis specification |
GO_0032729 | Biological process | positive regulation of type II interferon production |
GO_1903955 | Biological process | positive regulation of protein targeting to mitochondrion |
GO_0035567 | Biological process | non-canonical Wnt signaling pathway |
GO_0007416 | Biological process | synapse assembly |
GO_0060574 | Biological process | intestinal epithelial cell maturation |
GO_0060715 | Biological process | syncytiotrophoblast cell differentiation involved in labyrinthine layer development |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0031077 | Biological process | post-embryonic camera-type eye development |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0043204 | Cellular component | perikaryon |
GO_0031901 | Cellular component | early endosome membrane |
GO_0030669 | Cellular component | clathrin-coated endocytic vesicle membrane |
GO_0030425 | Cellular component | dendrite |
GO_0009986 | Cellular component | cell surface |
GO_0000139 | Cellular component | Golgi membrane |
GO_0045202 | Cellular component | synapse |
GO_0005923 | Cellular component | bicellular tight junction |
GO_0030424 | Cellular component | axon |
GO_0017147 | Molecular function | Wnt-protein binding |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0008289 | Molecular function | lipid binding |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0001540 | Molecular function | amyloid-beta binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0042813 | Molecular function | Wnt receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | FZD5 |
Protein name | Frizzled-5 (Fz-5) (hFz5) (FzE5) |
Synonyms | C2orf31 |
Description | FUNCTION: Receptor for Wnt proteins . Can activate WNT2, WNT10B, WNT5A, but not WNT2B or WNT4 (in vitro); the in vivo situation may be different since not all of these are known to be coexpressed (By similarity). In neurons, activation of WNT7A promotes formation of synapses . Functions in the canonical Wnt/beta-catenin signaling pathway. The canonical Wnt/beta-catenin signaling pathway leads to the activation of disheveled proteins, inhibition of GSK-3 kinase, nuclear accumulation of beta-catenin and activation of Wnt target genes (By similarity). A second signaling pathway involving PKC and calcium fluxes has been seen for some family members, but it is not yet clear if it represents a distinct pathway or if it can be integrated in the canonical pathway, as PKC seems to be required for Wnt-mediated inactivation of GSK-3 kinase. Both pathways seem to involve interactions with G-proteins. May be involved in transduction and intercellular transmission of polarity information during tissue morphogenesis and/or in differentiated tissues (Probable). Plays a role in yolk sac angiogenesis and in placental vascularization (By similarity). . |
Accessions | Q13467 ENST00000295417.4 |